急诊PCI对老年急性冠脉综合征患者的临床观察被引量：1

下载PDF

导出

摘要目的评价急诊PCI治疗老年急性冠脉综合征的疗效及安全性。方法68例老年急性冠脉综合征患者(>60岁)分为两组,其中分为PCI组36例,对照组32例。PCI组于发病12小时内行急诊PCI术;对照组给予尿激酶150万U静脉溶栓治疗。两组患者均长期服用抗凝、抗血小板药物及冠心病二级预防药物,观察1年内主要不良心脏事件的发生情况。结果PCI组主要不良心脏事件的发生率低于对照组,差异有统计学意义。结论急诊PCI治疗老年急性冠脉综合征安全性高,疗效可靠。

作者刘芳刘如平张成立

机构地区江苏省新沂市人民医院

出处《齐齐哈尔医学院学报》 2009年第22期2761-2762,共2页 Journal of Qiqihar Medical University

关键词老年急性冠脉综合征冠状动脉介入治疗

分类号 R541.4 [医药卫生—心血管疾病] R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1温尚煜黎辉.急性心肌梗死的介入治疗.中华综合医学杂志,2002,7:615-616.
2不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量：2694
3Thyesteant CA, Alpert JS. The definitions of acute coronary syndrome,myoeardial infarction mad unstable angina [J]. Cur Cardiol Rep,2001,3(4) :268- 272.
4Keely EL, Boura JA, Grines CL, et al. Primary angioplasty ver sus intravenous thrombolytic therapy for acute myocardial in farction:a quqntitative review of 23 randomised trials[J]. Lancet, 2003,361:13 - 20.
5Metha RH, Sadiq I,Goldbreg R J, et al. Effectiveness of percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infartion[J].Am Heart J,2004,147:253-259.
6Silber S, Albertsson P, Ariles FF, et al. Guidelines for percutaneous coronary interventions, the task force for pereutaneous coronary interventions of the european society of cardiology[J]. Eur Heart J,2005,26;804-847.
7李德云,马礼坤.急性冠脉综合征的诊断与治疗进展[J].国外医学（老年医学分册）,2007,28(4):173-177. 被引量：19

二级参考文献20

1Thygesen tCa, alpert JS. The definitions of acute coronary syndrome, myoeardial infarction, mad unstable angina. Cur Cardi01 Rep, 2001; 3 (4): 268-272
2Suraj AA, Suritl K, William A. Diagnosis of Acute Coronary Syndrome. Am FamPhysiciah, 2005, 72 (1) : 120 - 126
3Cheng CI, Yeh KH, Chang HW. Comparison of baseline characteristics, clinical features, anglographlc resuits and early outconles in men vs women with acute myocardial infarction undergoing primary coronary intervent Ion. Chest, 2004; 126 (1): 47-53
4Jacobs AK. COronary revas - ularization in women in 2003 sex levisited. Circulation, 2003; 107 (3) : 375 -377
5Kizer JR, Muttrej MR, Matthai WH. Role of cardiac troponin Tn the long - term risk stratifi% ation of patients un dergoing porcutaneous coronary intervent ion. Eur Heart J, 2003; 24 (14): 1314-122
6Dibra A, Mehflli J, Schwalger M. Predictive value of basal Creactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the .type of reperfusion treatment. Eur Heart J, 2003; 24 (12): 1128 - 1133
7Nesser HJ, Karia DH, Tkalec W et al. Therapeutic ultrasound in cardiology. Herz, 2002 ; 27 (3) : 269 - 278
8Szygula- Jurkiewicz B. Wilczek K, Szafron Bet al. In hospital observation of patients With acute coronary syndrome without ST elevation and muhivessels coronary artery disease treated with early invaslVe strategy. Comparison of results of percutaneous coronary intervent ion and coronary artery by - pass grafting. Pol Arcn Med Wewn, 2004 ; 112 (2) : 91 -918
9Frazier CG, Shah SH, Armstrong PW et al. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary syndromes (SYMPHONY) randomized clinical trials. Am Heart J, 2005 ; 150 (6): 1260 - 1267
10Rothberg MB, Celestin C, Fiore LD et al. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome : meta - analysis with estimates of risk and benefit. Ann Intern Med, 2005; 143 (4) : 24